Antivirals and antibiotics for influenza in the United States, 1995-2002

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 8, 2005, Pages 531-536

  Linder, Jeffrey A ^a   Bates, David W ^a   Platt, Richard ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti bacterial agents; Antiviral agents; Drug; Influenza; Physicians' practice patterns; Prescriptions

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CAUCASIAN; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SAMPLE SIZE; SEASONAL VARIATION; SEX DIFFERENCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; INFLUENZA, HUMAN; INSURANCE, HEALTH; MALE; MIDDLE AGED; ODDS RATIO; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 23844559250     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1067     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003; 52: 1-34.
2. Centers for Disease Control and Prevention. Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. MMWR 2000; 49: 619-622.
3. Couch RB. Prevention and treatment of influenza. N Engl J Med 2000; 343: 1778-1787.
4. Campion K, Silagy C, Keene O, et al. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998; 352: 1877-1881.
5. Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med 2001; 161: 212-217.
6. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283: 1016-1024.
7. Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med 2000; 160: 3234-3240.
8. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355: 1845-1850.
9. Monto AS, Webster A, Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother 1999; 44: 23-29.
10. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. Br Med J 2003; 326: 1235.
11. Libow LS, Neufeld RR, Olson E, Breuer B, Starer P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine. J Am Geriatr Soc 1996; 44: 1153-1157.
12. Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002; 50: 608-616.
13. Lee PY, Matchar DB, Clements DA, Huber J, Hamilton JD, Peterson ED. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. J Am Geriatr Soc 2002; 137: 225-231.
14. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003; 139: 321-329.
15. Rothberg MB, He S, Rose DN. Management of influenza symptoms in health adults: cost-effectiveness of rapid testing and antiviral therapy. J Gen Intern Med 2003; 18: 808-815.
16. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348: 1556-1564.
17. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116.
18. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992; 257: 1050-1055.
19. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 2001 summary. Advance data from vital and health statistics; no. 337. National Center for Health Statistics: Hyattsville, Maryland, 2003.
20. Hing E, Middleton K. National Hospital Ambulatory Medical Care Survey: 2001 outpatient department summary. Advance data from vital and health statistics; no. 338. National Center for Health Statistics: Hyattsville, Maryland, 2003.
21. McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2001 emergency department summary. Advance data from vital and health statistics; no. 335. National Center for Health Statistics: Hyattsville, Maryland, 2003.
22. National Center for Health Statistics. Public Use Microdata File Documentation, National Ambulatory Medical Care Survey, 2002. National Technical Information Service: Hyattsville, MD, 2004.
23. National Center for Health Statistics. Public Use Microdata File Documentation, National Hospital Ambulatory Medical Care Survey, 2002. National Technical Information Service: Hyattsville, MD, 2004.
24. Food and Drug Administration. National Drug Code Directory, 1995 Edition. Public Health Service: Washington DC, 1995.
25. Altman DE. The new Medicare prescription-drug legislation. N Engl J Med 2004; 350: 9-10.
26. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey 1989-1999. JAMA 2001; 286: 1181-1186.
27. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278: 901-904.
28. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med 2003; 138: 525-533.
29. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 2003; 289: 719-725.
30. Stone S, Gonzales R, Maselli J, Lowenstein SR. Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: a national study of hospital-based emergency departments. Ann Emerg Med 2000; 36: 320-327.
31. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160: 3243-3247.
32. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000; 31: 1166-1169.
33. Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SE, Walker AM. The effect of zanamivir treatment on influenza complications: a retrospective cohort study. Clin Ther 2002; 24: 1824-1839.
34. Centers for Disease Control and Prevention. Update: influenza activity - United States, January 18-24, 2004. MMWR 2004; 53: 63-65.